Mainz Biomed Nv (MYNZ)

$0.37

+0.04

(+13.32%)▲

Market is closed - opens 7 PM, 10 Sep 2024

Performance

  • $0.32
    $0.39
    $0.37
    downward going graph

    13.51%

    Downside

    Day's Volatility :17.72%

    Upside

    4.86%

    downward going graph
  • $0.31
    $4.38
    $0.37
    downward going graph

    17.3%

    Downside

    52 Weeks Volatility :93.01%

    Upside

    91.55%

    downward going graph

Returns

PeriodMainz Biomed NvIndex (Russel 2000)
3 Months
-54.01%
0.0%
6 Months
-69.2%
0.0%
1 Year
-90.31%
0.0%
3 Years
-96.73%
-20.6%

Highlights

Market Capitalization
7.2M
Book Value
$0.15
Earnings Per Share (EPS)
-1.62
Wall Street Target Price
2.0
Profit Margin
0.0%
Operating Margin TTM
-3068.71%
Return On Assets TTM
-93.42%
Return On Equity TTM
-303.2%
Revenue TTM
895.5K
Revenue Per Share TTM
0.06
Quarterly Revenue Growth YOY
11.1%
Gross Profit TTM
177.6K
EBITDA
-26.1M
Diluted Eps TTM
-1.62
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.87
EPS Estimate Next Year
-0.74
EPS Estimate Current Quarter
-0.25
EPS Estimate Next Quarter
-0.22

Analyst Recommendation

Buy
    77%Buy
    22%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Mainz Biomed Nv(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 440.54%

Current $0.37
Target $2.00

Technicals Summary

Sell

Neutral

Buy

Mainz Biomed Nv is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mainz Biomed Nv
Mainz Biomed Nv
-3.03%
-69.2%
-90.31%
-96.73%
-96.73%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
-1.58%
-13.85%
0.18%
-30.7%
76.49%
Agilent Technologies Inc.
Agilent Technologies Inc.
1.18%
-6.85%
21.31%
-22.59%
83.5%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
2.05%
1.99%
18.72%
6.88%
111.17%
Danaher Corp.
Danaher Corp.
-0.37%
5.3%
20.03%
-19.33%
94.89%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
5.02%
-6.0%
12.88%
-6.69%
61.6%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mainz Biomed Nv
Mainz Biomed Nv
NA
NA
NA
-0.87
-3.03
-0.93
NA
0.15
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
46.49
46.49
5.05
10.51
0.63
0.23
NA
19.16
Agilent Technologies Inc.
Agilent Technologies Inc.
28.76
28.76
2.99
5.24
0.25
0.08
0.01
20.53
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
37.6
37.6
2.26
21.75
0.14
0.05
0.0
124.17
Danaher Corp.
Danaher Corp.
48.58
48.58
2.63
7.58
0.08
0.04
0.0
68.92
Iqvia Holdings Inc.
Iqvia Holdings Inc.
32.24
32.24
1.22
11.2
0.23
0.05
NA
36.83
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mainz Biomed Nv
Mainz Biomed Nv
Buy
$7.2M
-96.73%
NA
0.0%
Idexx Laboratories, Inc.
Idexx Laboratories, Inc.
Buy
$38.9B
76.49%
46.49
22.34%
Agilent Technologies Inc.
Agilent Technologies Inc.
Buy
$39.8B
83.5%
28.76
21.75%
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc.
Buy
$233.5B
111.17%
37.6
14.69%
Danaher Corp.
Danaher Corp.
Buy
$192.3B
94.89%
48.58
17.83%
Iqvia Holdings Inc.
Iqvia Holdings Inc.
Buy
$45.2B
61.6%
32.24
9.39%

Insights on Mainz Biomed Nv

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 181.66K → 214.76K (in $), with an average increase of 7.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -8.25M → -5.18M (in $), with an average increase of 17.5% per quarter

  • Vs DHR

    In the last 1 year, Danaher Corp. has given 20.9% return, outperforming this stock by 110.8%

Company Information

mainz biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. we develop innovative products that quickly and easily identify the early onset of several leading deadly conditions including colorectal and pancreatic cancers. visit our website www.mainzbiomed.com to learn more about our company and our mission to save lives through science.

Organization
Mainz Biomed Nv
Employees
65
CEO
Mr. Guido Baechler
Industry
Miscellaneous

Discover More

FAQs